(Q44399593)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

2 December 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors (English)

1 reference

2 December 2017

Xu Hong

1

1 reference

2 December 2017

Lu Lei

2

1 reference

2 December 2017

Brita Künert

3

1 reference

2 December 2017

Rajender Naredla

4

1 reference

2 December 2017

Steven E Applequist

5

1 reference

2 December 2017

Alf Grandien

6

1 reference

2 December 2017

Rickard Glas

7

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

2 December 2017

1 reference

2 December 2017

67

1 reference

2 December 2017

15

1 reference

2 December 2017

7165-7174

1 reference

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

2 December 2017

2 references

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M312044200

COCI

reference URL

30 December 2023

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Current development of mTOR inhibitors as anticancer agents

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Radiosensitization of tumor cells by modulation of ATM kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A proteolytic system that compensates for loss of proteasome function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Centrosomal localization of DNA damage checkpoint proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

The role of apoptosis in cancer development and treatment response

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

The role of p53 in chemosensitivity and radiosensitivity.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A giant protease with a twist: the TPP II complex from Drosophila studied by electron microscopy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

The BRCT Domain Is a Phospho-Protein Binding Domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A giant protease with potential to substitute for some functions of the proteasome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Initiating cellular stress responses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Atm-deficient mice: a paradigm of ataxia telangiectasia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

p53 potentiates hippocampal neuronal death caused by global ischemia.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

ATM and ataxia telangiectasia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Post-translational modification of p53 in tumorigenesis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Enhanced radiation damage of tumor vasculature by mTOR inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Tripeptidyl-peptidase II: a multi-purpose peptidase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-06-4094

Identifiers

DOI

10.1158/0008-5472.CAN-06-4094

1 reference

2 December 2017

1 reference